Location: Cologne, Germany
Scalable, GMP manufacturing has become the constraint on which cell therapies reach patients. Cellistic will bring that conversation to BIO-Europe, November 9–11, 2026, in Cologne.
Jason Conner, Chief Executive Officer, will represent Cellistic on-site and join the panel "Driving Biopharma Growth Through Innovation," alongside industry peers, on Wednesday, November 11, from 10:30 to 11:00 a.m.
Cellistic has spent more than 15 years turning iPSC science into GMP manufacturing capacity, with a Belgium-based GMP facility. We are glad to talk with anyone at BIO-Europe about what your program needs next.
Reach out to Jason directly through the form below, or connect with Cellistic via partneringONE. We would welcome the chance to find time together in Cologne, or to host a visit at our GMP manufacturing facility, a two-hour drive away.